Cresco Labs Inc (CL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,413 | 146,609 | 155,354 | 137,564 | 153,295 |
| Receivables | 42,667 | 39,494 | 45,101 | 51,563 | 55,094 |
| Inventories | 92,804 | 89,173 | 86,884 | 83,343 | 92,238 |
| Other current assets | 52,573 | 20,023 | 6,604 | 5,667 | 4,904 |
| TOTAL | $242,643 | $314,605 | $311,093 | $294,257 | $311,918 |
| Non-Current Assets | |||||
| PPE Net | 426,938 | 433,734 | 446,376 | 455,503 | 465,141 |
| Investments And Advances | N/A | N/A | N/A | N/A | 651 |
| Intangibles | 575,483 | 572,752 | 576,801 | 577,478 | 579,280 |
| Other Non-Current Assets | 35,274 | 26,668 | 29,831 | 28,117 | 25,942 |
| TOTAL | $1,037,695 | $1,033,154 | $1,053,008 | $1,061,098 | $1,071,014 |
| Total Assets | $1,280,338 | $1,347,759 | $1,364,101 | $1,355,355 | $1,382,932 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,670 | 9,469 | 18,010 | 9,325 | 19,805 |
| Accounts payable and accrued liabilities | 17,367 | 16,990 | 18,284 | 13,651 | 19,155 |
| Accrued Expenses | 50,091 | 54,430 | 56,145 | 54,296 | 60,481 |
| Other current liabilities | 4,975 | 5,303 | N/A | N/A | N/A |
| TOTAL | $97,373 | $101,324 | $113,197 | $94,338 | $158,569 |
| Non-Current Liabilities | |||||
| Long Term Debt | 326,718 | 371,717 | 370,608 | 460,750 | 499,332 |
| Other Non-Current Liabilities | 332,738 | 322,790 | 310,481 | 304,485 | 252,602 |
| TOTAL | $842,794 | $885,523 | $875,335 | $872,841 | $858,996 |
| Total Liabilities | $940,167 | $986,847 | $988,532 | $967,179 | $1,017,565 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 357,415 | N/A | N/A | N/A | N/A |
| Common Shares | 1,718,063 | 1,716,641 | 1,714,279 | 1,706,822 | 1,705,575 |
| Retained earnings | -1,408,987 | -1,389,919 | -1,369,238 | -1,352,486 | -1,346,483 |
| Other shareholders' equity | -1,824 | -1,590 | -2,220 | -2,232 | -1,430 |
| TOTAL | $428,336 | $444,474 | $461,947 | $474,854 | $456,884 |
| Total Liabilities And Equity | $1,368,503 | $1,431,321 | $1,450,479 | $1,442,033 | $1,474,449 |